ARTICLE | Company News
Bial-Portela, moksha8 deal
August 11, 2014 7:00 AM UTC
Bial-Portela granted moksha8 an exclusive license to commercialize epilepsy treatment Zebinix eslicarbazepine acetate in Brazil and Mexico. The voltage-gated sodium and T-type calcium channel blocke...